F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Cisgender Women

Citing a lack of evidence, the agency will require Gilead to conduct additional trials.

Source: NYT Health - October 8, 2019 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Truvada (Drug) Women and Girls Drugs (Pharmaceuticals) Acquired Immune Deficiency Syndrome Inventions and Patents Transgender and Transsexuals Food and Drug Administration Gilead Sciences Inc your-feed-health Descovy Source Type: news